Trial Profile
Treatment With Rosiglitazone for the Prevention of Glucose Intolerance in Patients Treated With Corticosteroids
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Glucose intolerance
- Focus Therapeutic Use
- 16 Sep 2011 New trial record